73 related articles for article (PubMed ID: 15033457)
1. Cholesterol modulates P-glycoprotein activity in human peripheral blood mononuclear cells.
Troost J; Albermann N; Emil Haefeli W; Weiss J
Biochem Biophys Res Commun; 2004 Apr; 316(3):705-11. PubMed ID: 15033457
[TBL] [Abstract][Full Text] [Related]
2. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.
Gayet L; Dayan G; Barakat S; Labialle S; Michaud M; Cogne S; Mazane A; Coleman AW; Rigal D; Baggetto LG
Biochemistry; 2005 Mar; 44(11):4499-509. PubMed ID: 15766280
[TBL] [Abstract][Full Text] [Related]
3. Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells.
Troost J; Lindenmaier H; Haefeli WE; Weiss J
Mol Pharmacol; 2004 Nov; 66(5):1332-9. PubMed ID: 15308763
[TBL] [Abstract][Full Text] [Related]
4. Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity.
Gerrard G; Butters TD; Ganeshaguru K; Mehta AB
Eur J Pharmacol; 2009 May; 609(1-3):34-9. PubMed ID: 19285492
[TBL] [Abstract][Full Text] [Related]
5. Plasma LDL cholesterol has no impact on P-glycoprotein (MDR1/ABCB1) activity in human peripheral blood mononuclear cells.
Storch CH; Klimm HD; Heinrich T; Haefeli WE; Weiss J
Naunyn Schmiedebergs Arch Pharmacol; 2007 Oct; 376(1-2):135-43. PubMed ID: 17653693
[TBL] [Abstract][Full Text] [Related]
6. Intracellular accumulation of nelfinavir and its relationship to P-glycoprotein expression and function in HIV-infected patients.
Hennessy M; Clarke S; Spiers JP; Kelleher D; Mulcahy F; Hoggard P; Back D; Barry M
Antivir Ther; 2004 Feb; 9(1):115-22. PubMed ID: 15040543
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus.
Tsujimura S; Saito K; Nakayamada S; Nakano K; Tanaka Y
Arthritis Rheum; 2005 Jun; 52(6):1676-83. PubMed ID: 15934077
[TBL] [Abstract][Full Text] [Related]
8. The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane.
Garrigues A; Escargueil AE; Orlowski S
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10347-52. PubMed ID: 12145328
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide increases cell surface P-glycoprotein that exhibits diminished activity in intestinal epithelial cells.
Mishra J; Zhang Q; Rosson JL; Moran J; Dopp JM; Neudeck BL
Drug Metab Dispos; 2008 Oct; 36(10):2145-9. PubMed ID: 18687802
[TBL] [Abstract][Full Text] [Related]
10. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp.
Molnár J; Kars MD; Gündüz U; Engi H; Schumacher U; Van Damme EJ; Peumans WJ; Makovitzky J; Gyémánt N; Molnár P
Acta Histochem; 2009; 111(4):329-33. PubMed ID: 19124148
[TBL] [Abstract][Full Text] [Related]
11. Expression and activity of P-glycoprotein (MDR1/ABCB1) in peripheral blood mononuclear cells from patients with anorexia nervosa compared with healthy controls.
Storch CH; Nikendei C; Schild S; Haefeli WE; Weiss J; Herzog W
Int J Eat Disord; 2008 Jul; 41(5):432-8. PubMed ID: 18348284
[TBL] [Abstract][Full Text] [Related]
12. In vitro and ex vivo evidence for modulation of P-glycoprotein activity by progestins.
Fröhlich M; Albermann N; Sauer A; Walter-Sack I; Haefeli WE; Weiss J
Biochem Pharmacol; 2004 Dec; 68(12):2409-16. PubMed ID: 15548387
[TBL] [Abstract][Full Text] [Related]
13. Intracellular and plasma pharmacokinetics of nevirapine in human immunodeficiency virus-infected individuals.
Almond LM; Edirisinghe D; Dalton M; Bonington A; Back DJ; Khoo SH
Clin Pharmacol Ther; 2005 Aug; 78(2):132-42. PubMed ID: 16084848
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of caveolin-1 increases plasma membrane fluidity and reduces P-glycoprotein function in Hs578T/Dox.
Cai C; Zhu H; Chen J
Biochem Biophys Res Commun; 2004 Jul; 320(3):868-74. PubMed ID: 15240128
[TBL] [Abstract][Full Text] [Related]
15. Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in a vinblastine-resistant human lymphoblastic leukemia cell line.
Shu Y; Liu H
Biochem Cell Biol; 2007 Oct; 85(5):638-46. PubMed ID: 17901905
[TBL] [Abstract][Full Text] [Related]
16. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients.
Richaud-Patin Y; Vega-Boada F; Vidaller A; Llorente L
Biomed Pharmacother; 2004 Jun; 58(5):320-4. PubMed ID: 15194168
[TBL] [Abstract][Full Text] [Related]
18. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
19. Intracellular and plasma pharmacokinetics of nelfinavir and M8 in HIV-infected patients: relationship with P-glycoprotein expression.
Ford J; Cornforth D; Hoggard PG; Cuthbertson Z; Meaden ER; Williams I; Johnson M; Daniels E; Hsyu P; Back DJ; Khoo SH
Antivir Ther; 2004 Feb; 9(1):77-84. PubMed ID: 15040539
[TBL] [Abstract][Full Text] [Related]
20. Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein.
Griffin J; Fletcher N; Clemence R; Blanchflower S; Brayden DJ
J Vet Pharmacol Ther; 2005 Jun; 28(3):257-65. PubMed ID: 15953199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
